Schizophrenia pathogenic theory

WikiDoc Resources for Schizophrenia pathogenic theory

Articles

Most recent articles on Schizophrenia pathogenic theory

Most cited articles on Schizophrenia pathogenic theory

Review articles on Schizophrenia pathogenic theory

Articles on Schizophrenia pathogenic theory in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Schizophrenia pathogenic theory

Images of Schizophrenia pathogenic theory

Photos of Schizophrenia pathogenic theory

Podcasts & MP3s on Schizophrenia pathogenic theory

Videos on Schizophrenia pathogenic theory

Evidence Based Medicine

Cochrane Collaboration on Schizophrenia pathogenic theory

Bandolier on Schizophrenia pathogenic theory

TRIP on Schizophrenia pathogenic theory

Clinical Trials

Ongoing Trials on Schizophrenia pathogenic theory at Clinical Trials.gov

Trial results on Schizophrenia pathogenic theory

Clinical Trials on Schizophrenia pathogenic theory at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Schizophrenia pathogenic theory

NICE Guidance on Schizophrenia pathogenic theory

NHS PRODIGY Guidance

FDA on Schizophrenia pathogenic theory

CDC on Schizophrenia pathogenic theory

Books

Books on Schizophrenia pathogenic theory

News

Schizophrenia pathogenic theory in the news

Be alerted to news on Schizophrenia pathogenic theory

News trends on Schizophrenia pathogenic theory

Commentary

Blogs on Schizophrenia pathogenic theory

Definitions

Definitions of Schizophrenia pathogenic theory

Patient Resources / Community

Patient resources on Schizophrenia pathogenic theory

Discussion groups on Schizophrenia pathogenic theory

Patient Handouts on Schizophrenia pathogenic theory

Directions to Hospitals Treating Schizophrenia pathogenic theory

Risk calculators and risk factors for Schizophrenia pathogenic theory

Healthcare Provider Resources

Symptoms of Schizophrenia pathogenic theory

Causes & Risk Factors for Schizophrenia pathogenic theory

Diagnostic studies for Schizophrenia pathogenic theory

Treatment of Schizophrenia pathogenic theory

Continuing Medical Education (CME)

CME Programs on Schizophrenia pathogenic theory

International

Schizophrenia pathogenic theory en Espanol

Schizophrenia pathogenic theory en Francais

Business

Schizophrenia pathogenic theory in the Marketplace

Patents on Schizophrenia pathogenic theory

Experimental / Informatics

List of terms related to Schizophrenia pathogenic theory

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview[edit | edit source]

The pathogenic theory of schizophrenia, also called the germ theory of schizophrenia, is a pathogenic theory of disease in which it is thought that a proximal cause of certain cases of schizophrenia is the interaction of the developing fetus with pathogens such as viruses, or with antibodies from the mother created in response to these pathogens (in particular, Interleukin 8).[1]

Substantial research suggests that exposure to certain illnesses (e.g., influenza) in the mother of the neonate (especially at the end of the second trimester) causes defects in neural development which may emerge as a predisposition to schizophrenia around the time of puberty, as the brain grows and develops.[2]

## References[edit | edit source]

1. ↑ Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, Perrin M, Gorman JM, Susser ES.(2004) Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 161(5):889-95. PMID 15121655 (free full text) Am. Psych. Assn. Abstract:"OBJECTIVE: Many studies have implicated prenatal infection in the etiology of schizophrenia. Cytokines, a family of soluble polypeptides, are critically important in the immune response to infection and in other inflammatory processes. The goal of this study was to determine whether second-trimester levels of four cytokines—interleukin-8 (IL-8), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor- (TNF-)—are higher in the mothers of offspring who later developed schizophrenia spectrum disorders than in matched comparison subjects. METHOD: The authors conducted a nested case-control study of maternal serum cytokine levels in a large birth cohort, born 1959–1967. Cases (N=59) were subjects diagnosed with schizophrenia spectrum disorders (mostly schizophrenia and schizoaffective disorder) who had available second-trimester maternal serum samples. Comparison subjects (N=105) were members of the birth cohort, had not been diagnosed with a schizophrenia spectrum disorder or major affective disorder, and were matched to subjects with schizophrenia for date of birth, gender, length of time in the cohort, and availability of maternal sera. Maternal second-trimester serum levels of IL-8, IL-1β, IL-6, and TNF- were determined by sandwich enzyme-linked immunosorbent assay. RESULTS: The second-trimester IL-8 levels in mothers of offspring with schizophrenia spectrum disorders were significantly higher than those of the mothers of comparison subjects. There were no differences between subjects with schizophrenia and comparison subjects with respect to maternal levels of IL-1β, IL-6, or TNF-. CONCLUSIONS: Using prospectively collected prenatal sera in a large and well-characterized birth cohort, the authors have documented a significant association between maternal IL-8 level during the second trimester and risk of schizophrenia spectrum disorders in the offspring. These findings provide further support for a substantive role of in utero infection or inflammation in the etiology of schizophrenia. Moreover, these results may have important implications for elucidating the mechanisms by which disrupted fetal development raises the risk of this disorder." (Emphasis supplied.)
2. ↑ Brown, Alan S. (Columbia University) Prenatal infection as a risk factor for schizophrenia Schizophrenia Bulletin, doi:10.1093/schbul/sbj052 (Oxford Univ. Feb. 2006) Abstract: "Accumulating evidence suggests that prenatal exposure to infection contributes to the etiology of schizophrenia. This line of investigation has been advanced by birth cohort studies that utilize prospectively acquired data from serologic assays for infectious and immune biomarkers. These investigations have provided further support for this hypothesis and permitted the investigation of new infectious pathogens in relation to schizophrenia risk. Prenatal infections that have been associated with schizophrenia include rubella, influenza, and toxoplasmosis. Maternal cytokines, including interleukin-8, are also significantly increased in pregnancies giving rise to schizophrenia cases. Although replication of these findings is required, this body of work may ultimately have important implications for the prevention of schizophrenia, the elaboration of pathogenic mechanisms in this disorder, and investigations of gene-environment interactions."

Template:WH Template:WS